Liraglutide
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
Novo Nordisk · Phase 3 · Completed · Enrollment 422
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Lira 3.0 mg | 50.5% | 26.1% | n/r | n/r |
| Placebo | 21.9% | 6.3% | n/r | n/r |
Not shown
Every selected arm is drawn.